| RMEBX | TVLIX | RMEBX / TVLIX | |
| Total Expense Ratio | 1.07 | 0.68 | 157% |
| Annual Report Gross Expense Ratio | 1.07 | 0.81 | 132% |
| Fund Existence | 11 years | 19 years | - |
| Gain YTD | 14.812 | 9.934 | 149% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 500000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 112B | 620M | 18,065% |
| Annual Yield % from dividends | 1.03 | 1.38 | 74% |
| Returns for 1 year | 5.38 | -3.01 | -179% |
| Returns for 3 years | 26.56 | 21.85 | 122% |
| Returns for 5 years | 51.74 | 41.36 | 125% |
| Returns for 10 years | 87.74 | 56.52 | 155% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IEUR | 69.47 | 0.29 | +0.42% |
| iShares Core MSCI Europe ETF | |||
| BFRZ | 26.83 | 0.02 | +0.07% |
| Innovator Equity Managed 100 Buffer ETF | |||
| DFVE | 31.69 | N/A | -0.01% |
| DoubleLine Fortune 500 Equal Weight ETF | |||
| PZT | 22.36 | -0.04 | -0.18% |
| Invesco New York AMT-Free Muni Bd ETF | |||
| BME | 40.76 | -0.26 | -0.65% |
| Blackrock Health Sciences Trust | |||